JP2008531702A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531702A5
JP2008531702A5 JP2007558127A JP2007558127A JP2008531702A5 JP 2008531702 A5 JP2008531702 A5 JP 2008531702A5 JP 2007558127 A JP2007558127 A JP 2007558127A JP 2007558127 A JP2007558127 A JP 2007558127A JP 2008531702 A5 JP2008531702 A5 JP 2008531702A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
group
alkoxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/007049 external-priority patent/WO2006093947A2/en
Publication of JP2008531702A publication Critical patent/JP2008531702A/ja
Publication of JP2008531702A5 publication Critical patent/JP2008531702A5/ja
Pending legal-status Critical Current

Links

JP2007558127A 2005-02-28 2006-02-27 抗菌活性を有する半合成グリコペプチド Pending JP2008531702A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65729705P 2005-02-28 2005-02-28
PCT/US2006/007049 WO2006093947A2 (en) 2005-02-28 2006-02-27 Semi-synthetic glycopeptides with antibiotic activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009035666A Division JP2009102446A (ja) 2005-02-28 2009-02-18 抗菌活性を有する半合成グリコペプチド

Publications (2)

Publication Number Publication Date
JP2008531702A JP2008531702A (ja) 2008-08-14
JP2008531702A5 true JP2008531702A5 (cg-RX-API-DMAC7.html) 2009-04-09

Family

ID=36941732

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558127A Pending JP2008531702A (ja) 2005-02-28 2006-02-27 抗菌活性を有する半合成グリコペプチド
JP2009035666A Pending JP2009102446A (ja) 2005-02-28 2009-02-18 抗菌活性を有する半合成グリコペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009035666A Pending JP2009102446A (ja) 2005-02-28 2009-02-18 抗菌活性を有する半合成グリコペプチド

Country Status (10)

Country Link
US (1) US7632918B2 (cg-RX-API-DMAC7.html)
EP (1) EP1861115A4 (cg-RX-API-DMAC7.html)
JP (2) JP2008531702A (cg-RX-API-DMAC7.html)
KR (1) KR20080004455A (cg-RX-API-DMAC7.html)
CN (1) CN101222933A (cg-RX-API-DMAC7.html)
AU (1) AU2006218665A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0607702A2 (cg-RX-API-DMAC7.html)
CA (1) CA2600453A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007010478A (cg-RX-API-DMAC7.html)
WO (1) WO2006093947A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
WO2009085562A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
CN101343313B (zh) * 2008-09-03 2011-11-16 南京农业大学 一种葡萄糖二肽类化合物及其制备方法和用途
WO2010048340A2 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN101928330B (zh) * 2009-06-26 2013-10-16 上海来益生物药物研究开发中心有限责任公司 一种新的化合物及其应用
WO2016103284A1 (en) 2014-12-25 2016-06-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
JP2018515481A (ja) * 2015-09-16 2018-06-14 シュアンチュー ファーマ カンパニー,リミティド β−ラクタマーゼ阻害剤とその利用
CN107619433B (zh) * 2016-07-15 2023-03-17 上海来益生物药物研究开发中心有限责任公司 糖肽类衍生物及其药学可接受的盐、制备方法和应用
KR102661786B1 (ko) * 2017-05-22 2024-04-26 인스메드 인코포레이티드 글리코펩티드 유도체 화합물 및 이의 용도
CN109422800A (zh) * 2017-08-22 2019-03-05 复旦大学 抗革兰氏阳性菌季铵盐糖肽类化合物及其药用用途
CN108774158A (zh) * 2018-06-20 2018-11-09 南京肽业生物科技有限公司 一种Fmoc和疏水性氨基酸的反应
CN110938114B (zh) * 2018-09-21 2023-04-28 中国科学院上海药物研究所 一类万古霉素硫鎓衍生物、其制备方法、药物组合物和用途
US20210388028A1 (en) * 2018-11-21 2021-12-16 Insmed Incorporated Glycopeptide derivative compounds and uses thereof
JP2023091200A (ja) * 2021-12-20 2023-06-30 花王株式会社 有機化合物、試薬、及び分析方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3011278B1 (de) 1980-03-24 1981-04-02 Rohde & Schwarz GmbH & Co KG, 8000 München Funkpeiler
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
GB8522574D0 (en) * 1985-09-12 1985-10-16 Lepetit Spa Amides of teicoplanin compounds
GB8701872D0 (en) 1987-01-28 1987-03-04 Lepetit Spa N15-alkyl & n15,n15-dialkyl derivatives
CA1339808C (en) 1988-10-19 1998-04-07 Manuel Debono Glycopeptide antibiotics
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
NZ270387A (en) 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) * 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
PL198311B1 (pl) * 1998-12-23 2008-06-30 Theravance Związki glikopeptydowe, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
WO2000059528A1 (en) 1999-04-02 2000-10-12 The Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
AU5029700A (en) * 1999-05-19 2000-12-05 Merck & Co., Inc. Glycopeptide antibacterial compounds, compositions containing same and methods of using same
AU3818001A (en) 2000-02-11 2001-08-20 Lilly Co Eli Selective n-acylation of a82846 glycopeptide analogs
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) * 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
KR20060091049A (ko) 2002-08-30 2006-08-17 케이.유.루벤 리서치 앤드 디벨럽먼트 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용
WO2004044222A2 (en) * 2002-11-12 2004-05-27 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US20070185015A1 (en) 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity

Similar Documents

Publication Publication Date Title
JP2008531702A5 (cg-RX-API-DMAC7.html)
RU94020407A (ru) Имидазолидильные макролиды, способ их получения, фармацевтическая композиция, способ лечения
JP2012509846A5 (cg-RX-API-DMAC7.html)
JP2008505858A5 (cg-RX-API-DMAC7.html)
CA2459449A1 (en) Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
US10293021B2 (en) Conjugates and prodrugs for treating cancer and inflammatory diseases
JP2002505337A5 (cg-RX-API-DMAC7.html)
FR2515182A1 (fr) Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
CN1215397A (zh) 具有免疫调解剂作用的酰化n-羟甲基酞胺哌啶酮-前药
EP0001024B1 (fr) Forme cristalline du sel de sodium d'un dérivé oximiné de l'acide 7-amino thiazolyl acétamido céphalosporanique, son procédé de préparation et les compositions pharmaceutiques la renfermant
DE68928925T2 (de) Antimikrobielle Fluorochinolonylcephemderivate
JP2006515866A5 (cg-RX-API-DMAC7.html)
JP6404358B2 (ja) マルトール第二鉄の結晶形態
JP2008531713A5 (cg-RX-API-DMAC7.html)
JP2008508287A5 (cg-RX-API-DMAC7.html)
RU2003134629A (ru) Соединения цефема
KR20030016231A (ko) 티아졸륨 화합물, 및 단백질 노화와 관련된 장애의 치료
JP2008531701A5 (cg-RX-API-DMAC7.html)
CH629815A5 (en) Oximes derived from 7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
JP2010502568A5 (cg-RX-API-DMAC7.html)
CZ279343B6 (cs) Nové kyseliny 3,3` -dithiobis(propionové) a jejich estery
JPH05501879A (ja) Hivおよび他のレトロウイルスを処理する方法およびそれに有用な化合物
WO2006030217A2 (en) Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
WO2007005491B1 (en) Hydrazide conjugates as imaging agents
FR2539128A1 (fr) Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation